Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected Patients

• Status: Completed
• Trial end date: 2007-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this clinical research study is to assess the effect of Famotidine given twice daily on Atazanavir administered with Ritonavir in HIV-Infected subjects.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bristol-Myers Squibb
• Treatments: Atazanavir Sulfate; Famotidine; Ritonavir; Tenofovir

Criteria

Inclusion Criteria:

• HIV-infected male and female subjects between the ages of 18 to 65 years old with a BMI 18 to 35 kg/m²

• Prior to enrollment subjects must be currently receiving Atazanavir/Ritonavir plus at least 2 NRTIs, must have plasma HIV RNA <400 copies/mL and have CD4 count >200 cells/mm³